Skip to main content
Premium Trial:

Request an Annual Quote

Mobilion, Protein Metrics Partner on Ion Mobility Mass Spec Data Analysis Tools

NEW YORK – Chromatography firm Mobilion Systems said Tuesday that it has formed a strategic partnership with informatics company Protein Metrics to provide data-analysis tools for Mobilion's high-resolution ion mobility (HRIM) mass spectrometry system.

The partners look to tackle the biopharma market where they believe the combination of Mobilion's HRIM technology and Protein Metrics' Byos data-analysis software will improve and accelerate the analysis of critical quality attributes in biotherapeutic development.

According to Chadds Ford, Pennsylvania-based Mobilion, its HRIM platform allows for two-minute high-resolution released glycan analysis and five-minute peptide mapping analysis while also improving monitoring of protein post-translational modifications.

"Combining the fastest, highest resolution, most reproducible therapeutic protein analysis with simple, automated data analysis and visualization provides our mutual pharmaceutical customers with a streamlined workflow that will help bring safer, more efficacious drugs to market faster," Mobilion CEO Melissa Sherman said in a statement. "The push-button, software-driven approach of both the sample analysis and data analysis deliver the speed and efficiency our customers seek."

"With over 100 companies worldwide trusting our protein analysis workflows and an industry-recognized gold standard in glycan analysis, this partnership enables our client base to rapidly integrate cutting edge platforms with confidence and ease," said Kevin Cronin, vice president of corporate development at Cupertino, California-based Protein Metrics.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.